Pdt Partners, LLC Roivant Sciences Ltd. Transaction History
Pdt Partners, LLC
- $1 Billion
- Q4 2024
A detailed history of Pdt Partners, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Pdt Partners, LLC holds 508,431 shares of ROIV stock, worth $5.45 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
508,431
Previous 399,107
27.39%
Holding current value
$5.45 Million
Previous $4.61 Million
30.6%
% of portfolio
0.6%
Previous 0.45%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$705 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$665 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$512 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$472 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$379 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.54B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...